2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes …

F Cosentino, PJ Grant, V Aboyans… - European heart …, 2020 - academic.oup.com
Health professionals are encouraged to take the Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

Prognosis of unrecognised myocardial infarction determined by electrocardiography or cardiac magnetic resonance imaging: systematic review and meta-analysis

Y Yang, W Li, H Zhu, XF Pan, Y Hu, C Arnott, W Mai… - bmj, 2020 - bmj.com
Objective To evaluate the prognosis of unrecognised myocardial infarction determined by
electrocardiography (UMI-ECG) or cardiac magnetic resonance imaging (UMI-CMR). Design …

[HTML][HTML] Prevalence of ECG abnormalities in people with type 2 diabetes: the Hoorn Diabetes Care System cohort

PP Harms, AA van der Heijden, F Rutters… - Journal of Diabetes and …, 2021 - Elsevier
Abstract Aims The American Diabetes Association, and the joint European Society of
Cardiology and European Association for the Study of Diabetes guidelines recommend a …

Prediabetes deserves more attention: a review

Y Lawal, F Bello, YS Kaoje - Clinical Diabetes, 2020 - Am Diabetes Assoc
Evidence increasingly demonstrates that prediabetes is a toxic state, as well as a risk factor
for diabetes, and is associated with pathophysiological changes in several tissues and …

Diabetes e doença cardiovascular

C Guamán, W Acosta, C Alvarez… - Revista Uruguaya de …, 2021 - scielo.edu.uy
Diabetes y enfermedad cardiovascular Page 1 Diabetesyenfermedadcardiovascular
CarlosGuamán,WilliamAcosta,CarlaAlvarez,BenhardHasbum Diabetes y enfermedad …

Российское медицинское общество по артериальной гипертонии. Рекомендации по ведению больных артериальной гипертонией с метаболическими …

ИЕ Чазова, МВ Шестакова, ЮВ Жернакова… - Системные …, 2020 - cyberleninka.ru
Российское медицинское общество по артериальной гипертонии. Рекомендации по
ведению больных артериальной гипертонией с метаболическими нарушениями и …

The interaction between gender and diabetes mellitus in the coronary heart disease risk

E Oikonomou, V Tsigkou… - Current …, 2016 - ingentaconnect.com
Background: Cardiovascular disease (CVD) despite the advances in medical management
keeps on as the primary cause of morbidity and mortality for both genders in Western …

Impact of polycystic ovary syndrome on silent coronary artery disease and cardiovascular events; a long-term population-based cohort study

F Mahboobifard, M Rahmati, A Niknam… - Archives of Medical …, 2022 - Elsevier
Background The existing data regarding the impact of Polycystic Ovary Syndrome (PCOS)
on the risk of developing cardiovascular disease (CVD) are conflicting. Aim To explore the …

Identification of silent myocardial ischemia in patients with long-term type 1 and type 2 diabetes

D Rokicka, A Bożek, M Wróbel… - International Journal of …, 2022 - mdpi.com
(1) Background: This study aimed to analyze epidemiological data to identify risk factors for
silent myocardial ischemia in patients with long-term type 1 and type 2 diabetes.(2) Methods …

Guidelines on treatment of patients with arterial hypertension comorbid with metabolic disorders and diabetes mellitus type 2

IE Chazova, MV Shestakova… - Systemic …, 2020 - journals.eco-vector.com
Рекомендации по ведению больных артериальной гипертонией с метаболи Page 1
Systemic Hypertension. 2020; 17 (1): 7–45. 7 Рекомендации Российское медицинское …